Professors Provide Most Updated Information on Aspirin in the Prevention of a First Heart Attack

Released: 2-Sep-2014 3:00 PM EDT
Source Newsroom: Florida Atlantic University
Expert Available
Contact Information

Available for logged-in reporters only

Citations Trends in Cardiovascular Medicine

Newswise — The first researcher in the world to discover that aspirin prevents a first attack, Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University, has published a comprehensive review in the current issue of the journal Trends in Cardiovascular Medicine. Hennekens and his coauthor James E. Dalen, M.D., M.P.H., executive director of the Weil Foundation and dean emeritus, University of Arizona College of Medicine, provide the most updated information on aspirin in the prevention of a first heart attack. Hennekens also presented these findings from the article titled “Aspirin in the Primary Prevention of Cardiovascular Disease: Current Knowledge and Future Research Needs,” on Saturday, Aug. 30 at a “Meet the Experts” lecture at the European Society of Cardiology meetings in Barcelona, Spain. Serving as chair of a symposium on Sunday, Aug. 31, he also delivered a lecture on “Evolving Concepts in Cardiovascular Prevention: Aspirin Then and Now.”

In the article, Hennekens and Dalen emphasize that the evidence in treatment indicates that all patients having a heart attack or who have survived a prior event should be given aspirin. In healthy individuals, however, they state that any decision to prescribe aspirin should be an individual clinical judgment by the healthcare provider that weighs the absolute benefit in reducing the risk of a first heart against the absolute risk of major bleeding.

“The crucial role of therapeutic lifestyle changes and other drugs of life saving benefit such as statins should be considered with aspirin as an adjunct, not alternative,” said Hennekens. “The benefits of statins and aspirin are, at the very least, additive. The more widespread and appropriate use of aspirin in primary prevention is particularly attractive, especially in developing countries where cardiovascular disease is emerging as the leading cause of death.”

Hennekens also notes that aspirin is generally widely available over the counter and is extremely inexpensive. He cautions, however, that more evidence is necessary in intermediate risk subjects before general guidelines should be made.

Among the numerous honors and recognition Hennekens has received include the 2013 Fries Prize for Improving Health for his seminal contributions to the treatment and prevention of cardiovascular disease, the 2013 Presidential Award from his alma mater, Queens College for his distinguished contributions to society, the 2013 honoree as part of FAU’s Charles E. Schmidt College of Medicine from the American Heart Association for reducing deaths from heart attacks and strokes, and the 2014 honoree from the Ochsner Foundation for his seminal research on smoking and disease.

From 1995 to 2005, Science Watch ranked Hennekens as the third most widely cited medical researcher in the world and five of the top 20 were his former trainees and/or fellows. In 2012, Science Heroes ranked Hennekens No. 81 in the history of the world for having saved more than 1.1 million lives.

– FAU –

About Florida Atlantic University:
Florida Atlantic University, established in 1961, officially opened its doors in 1964 as the fifth public university in Florida. Today, the University, with an annual economic impact of $6.3 billion, serves more than 30,000 undergraduate and graduate students at sites throughout its six-county service region in southeast Florida. FAU’s world-class teaching and research faculty serves students through 10 colleges: the Dorothy F. Schmidt College of Arts and Letters, the College of Business, the College for Design and Social Inquiry, the College of Education, the College of Engineering and Computer Science, the Graduate College, the Harriet L. Wilkes Honors College, the Charles E. Schmidt College of Medicine, the Christine E. Lynn College of Nursing and the Charles E. Schmidt College of Science. FAU is ranked as a High Research Activity institution by the Carnegie Foundation for the Advancement of Teaching. The University is placing special focus on the rapid development of three signature themes – marine and coastal issues, biotechnology and contemporary societal challenges – which provide opportunities for faculty and students to build upon FAU’s existing strengths in research and scholarship. For more information, visit www.fau.edu.


Comment/Share